Testing effectiveness (Phase 2)UnknownNCT06042764
What this trial is testing
SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients
Who this might be right for
Infection of Upper Respiratory Tract Caused by 2019-nCoV
Sinovac Life Sciences Co., Ltd. 150